NorthStar will use the accelerators at its headquarters in Beloit, WI, to expand its molybdenum-99 (Mo-99) commercial production capabilities. The company had previously purchased three Rhodotron TT300 HE electron-beam accelerators, including two in 2019 for production of Mo-99 and one in 2020 for the commercial production of actinium-225 (Ac-225).